PMC:7105881 / 19783-20107 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"695","span":{"begin":5,"end":13},"obj":"Species"},{"id":"696","span":{"begin":18,"end":26},"obj":"Species"}],"attributes":[{"id":"A695","pred":"tao:has_database_id","subj":"695","obj":"Tax:694009"},{"id":"A696","pred":"tao:has_database_id","subj":"696","obj":"Tax:1335626"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Most SARS-CoV and MERS-CoV vaccines developed thus far are based on the inactivated or live attenuated viruses, DNAs, proteins, nanoparticles, viral vectors, including virus-like particles (VLPs) (Zeng et al., 2004; Jiang et al., 2005; Liu et al., 2005; Du et al., 2009a, 2016b; Pimentel et al., 2009; Al-Amri et al., 2017)."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T84","span":{"begin":118,"end":126},"obj":"Body_part"}],"attributes":[{"id":"A84","pred":"fma_id","subj":"T84","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Most SARS-CoV and MERS-CoV vaccines developed thus far are based on the inactivated or live attenuated viruses, DNAs, proteins, nanoparticles, viral vectors, including virus-like particles (VLPs) (Zeng et al., 2004; Jiang et al., 2005; Liu et al., 2005; Du et al., 2009a, 2016b; Pimentel et al., 2009; Al-Amri et al., 2017)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T79","span":{"begin":5,"end":13},"obj":"Disease"}],"attributes":[{"id":"A79","pred":"mondo_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Most SARS-CoV and MERS-CoV vaccines developed thus far are based on the inactivated or live attenuated viruses, DNAs, proteins, nanoparticles, viral vectors, including virus-like particles (VLPs) (Zeng et al., 2004; Jiang et al., 2005; Liu et al., 2005; Du et al., 2009a, 2016b; Pimentel et al., 2009; Al-Amri et al., 2017)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T230","span":{"begin":103,"end":110},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T231","span":{"begin":168,"end":173},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"Most SARS-CoV and MERS-CoV vaccines developed thus far are based on the inactivated or live attenuated viruses, DNAs, proteins, nanoparticles, viral vectors, including virus-like particles (VLPs) (Zeng et al., 2004; Jiang et al., 2005; Liu et al., 2005; Du et al., 2009a, 2016b; Pimentel et al., 2009; Al-Amri et al., 2017)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T81","span":{"begin":118,"end":126},"obj":"Chemical"},{"id":"T82","span":{"begin":128,"end":141},"obj":"Chemical"},{"id":"T83","span":{"begin":302,"end":304},"obj":"Chemical"}],"attributes":[{"id":"A81","pred":"chebi_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A82","pred":"chebi_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/CHEBI_50803"},{"id":"A83","pred":"chebi_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/CHEBI_28984"}],"text":"Most SARS-CoV and MERS-CoV vaccines developed thus far are based on the inactivated or live attenuated viruses, DNAs, proteins, nanoparticles, viral vectors, including virus-like particles (VLPs) (Zeng et al., 2004; Jiang et al., 2005; Liu et al., 2005; Du et al., 2009a, 2016b; Pimentel et al., 2009; Al-Amri et al., 2017)."}

{"project":"2_test","denotations":[{"id":"32265848-14985131-36511075","span":{"begin":210,"end":214},"obj":"14985131"},{"id":"32265848-16022774-36511076","span":{"begin":230,"end":234},"obj":"16022774"},{"id":"32265848-16022898-36511077","span":{"begin":248,"end":252},"obj":"16022898"},{"id":"32265848-19152635-36511080","span":{"begin":296,"end":300},"obj":"19152635"},{"id":"32265848-28332568-36511081","span":{"begin":318,"end":322},"obj":"28332568"}],"text":"Most SARS-CoV and MERS-CoV vaccines developed thus far are based on the inactivated or live attenuated viruses, DNAs, proteins, nanoparticles, viral vectors, including virus-like particles (VLPs) (Zeng et al., 2004; Jiang et al., 2005; Liu et al., 2005; Du et al., 2009a, 2016b; Pimentel et al., 2009; Al-Amri et al., 2017)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T123","span":{"begin":0,"end":324},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Most SARS-CoV and MERS-CoV vaccines developed thus far are based on the inactivated or live attenuated viruses, DNAs, proteins, nanoparticles, viral vectors, including virus-like particles (VLPs) (Zeng et al., 2004; Jiang et al., 2005; Liu et al., 2005; Du et al., 2009a, 2016b; Pimentel et al., 2009; Al-Amri et al., 2017)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T383","span":{"begin":5,"end":13},"obj":"SP_10"},{"id":"T384","span":{"begin":18,"end":26},"obj":"SP_9"},{"id":"T385","span":{"begin":103,"end":110},"obj":"NCBITaxon:10239"},{"id":"T386","span":{"begin":143,"end":148},"obj":"NCBITaxon:10239;SO:0000440"},{"id":"T387","span":{"begin":149,"end":156},"obj":"SO:0000440"},{"id":"T388","span":{"begin":168,"end":173},"obj":"NCBITaxon:10239"},{"id":"T97925","span":{"begin":5,"end":13},"obj":"SP_10"},{"id":"T48234","span":{"begin":18,"end":26},"obj":"SP_9"},{"id":"T81231","span":{"begin":103,"end":110},"obj":"NCBITaxon:10239"},{"id":"T61713","span":{"begin":143,"end":148},"obj":"NCBITaxon:10239;SO:0000440"},{"id":"T21939","span":{"begin":149,"end":156},"obj":"SO:0000440"},{"id":"T81441","span":{"begin":168,"end":173},"obj":"NCBITaxon:10239"}],"text":"Most SARS-CoV and MERS-CoV vaccines developed thus far are based on the inactivated or live attenuated viruses, DNAs, proteins, nanoparticles, viral vectors, including virus-like particles (VLPs) (Zeng et al., 2004; Jiang et al., 2005; Liu et al., 2005; Du et al., 2009a, 2016b; Pimentel et al., 2009; Al-Amri et al., 2017)."}